FSD Pharma Provides Update on Celly Nu's New Packaging for unbuzzd(TM)
Celly Nutrition Corp and Six+One Unveil New Packaging and Logo for unbuzzd(TM) Expected Launch This Summer [Yahoo! Finance]
FSD Pharma Inc. (NASDAQ: HUGE) had its "buy-venture" rating re-affirmed by analysts at Singular Research.
FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia
FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol Intoxication